Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tatsuki Doijiri
Observed name:
Doijiri, Tatsuki
Institution:
Seiwa Hospital
Observed institutions:
Seiwa Hospital,
Kanazawa Municipal Hospital,
Kumamoto Orthopedic Surgery Hospital,
Yawata Medical Center,
Saiseikai Yokohama Eastern Hospital,
Kokura Memorial Hospital
show all 6
ORCID:
0009-0009-1345-6131
Observed ORCID:
0009-0009-1345-6131
OpenAlex ID:
A5025794310
Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation
2017
·
Masato Nakamura
, Raisuke Iijima
, et al.
·
JACC: Cardiovascular Interventions
·
117
PDF
Prevalence and Clinical Outcome of Polyvascular Atherosclerotic Disease in Patients Undergoing Coronary Intervention
2012
·
Takashi Miura
, Yoshimitsu Soga
, et al.
·
Circulation Journal
·
56
PDF
1-Year Outcomes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions
2022
·
Tatsuya Nakama
, Mitsuyoshi Takahara
, et al.
·
JACC: Cardiovascular Interventions
·
46
Drug-Eluting Versus Bare-Metal Stent Implantation With or Without Cilostazol in the Treatment of the Superficial Femoral Artery: The DEBATE in SFA Study
2018
·
Takashi Miura
, Yusuke Miyashita
, et al.
·
Circulation Cardiovascular Interventions
·
41
Cardiovascular Outcome and Mortality in Patients Undergoing Endovascular Treatment for Symptomatic Peripheral Artery Disease ― Short-Term Results of the Toma-Code Registry ―
2018
·
Michiaki Higashitani
, Yukari Uemura
, et al.
·
Circulation Journal
·
28
PDF
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial
2024
·
Yuki Obayashi
, Masahiro Natsuaki
, et al.
·
European Heart Journal - Cardiovascular Pharmacotherapy
·
13
PDF
Risk Factors and Outcomes of Recurrent Drug‐Eluting Stent Thrombosis: Insights From the REAL‐ST Registry
2021
·
Soichiro Enomoto
, Shoichi Kuramitsu
, et al.
·
Journal of the American Heart Association
·
13
PDF
One-Year Clinical Outcomes following Implantation of InnovaTM Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions
2019
·
Takuya Tsujimura
, Mitsuyoshi Takahara
, et al.
·
Journal of Atherosclerosis and Thrombosis
·
13
PDF
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention
2024
·
Ko Yamamoto
, Masahiro Natsuaki
, et al.
·
JACC: Cardiovascular Interventions
·
11
PDF
Multicenter Registry of Common Femoral Artery Disease Treated With Endovascular Revascularization Using Interwoven Nitinol Stents: An Observational Retrospective Study
2024
·
Kazunori Horie
, Mitsuyoshi Takahara
, et al.
·
Journal of Endovascular Therapy
·
10
Comparison Between Clinical Outcomes of Low- and High-Dose Paclitaxel Drug-Coated Balloon in Endovascular Therapy for Femoropopliteal Lesion
2022
·
Shinsuke Mori
, Yasutaka Yamauchi
, et al.
·
CardioVascular and Interventional Radiology
·
10
Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy
2022
·
Osami Kawarada
, Kan Zen
, et al.
·
Journal of Endovascular Therapy
·
9
Clinical Impact of the Ankle-Brachial Index in Patients Undergoing Successful Percutaneous Coronary Intervention
2018
·
Seiichi Hiramori
, Yoshimitsu Soga
, et al.
·
Circulation Journal
·
9
PDF
Crossover stenting across the deep femoral artery entry: a multicenter retrospective study
2017
·
Yo Iwata
, Daisuke Ueshima
, et al.
·
Cardiovascular Intervention and Therapeutics
·
8
Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
2022
·
Takashi Miura
, Yusuke Miyashita
, et al.
·
PLoS ONE
·
7
PDF
Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve Assessment
2022
·
Yasutsugu Shiono
, Shoichi Kuramitsu
, et al.
·
JACC: Cardiovascular Interventions
·
7
Mortality risk after use of a paclitaxel-coated stent in femoropopliteal peripheral artery disease
2021
·
Michinao Tan
, Kazushi Urasawa
, et al.
·
Cardiovascular Intervention and Therapeutics
·
7
Prognostic Impact of Renal Function on 5‐Year Outcomes After Fractional Flow Reserve‐Guided Deferral of Revascularization
2023
·
Ryosuke Itakura
, Shoichi Kuramitsu
, et al.
·
Journal of the American Heart Association
·
6
PDF
Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan
2017
·
Shinsuke Mori
, Keisuke Hirano
, et al.
·
Heart and Vessels
·
5
Treatment for LMCA ostial stenosis using a bifurcation technique with a retrograde approach
2009
·
Shinichi Shirai
, Tatsuki Doijiri
, et al.
·
Catheterization and Cardiovascular Interventions
·
5
Sex Differences in 5-Year Outcomes After Deferral of Revascularization Following Physiological Coronary Assessment
2024
·
Takayuki Ishihara
, Shoichi Kuramitsu
, et al.
·
Circulation Reports
·
4
PDF
An Aspirin-Free Strategy for Patients Undergoing Staged Percutaneous Coronary Intervention ― A Subgroup Analysis of the STOPDAPT-3 Trial ―
2025
·
Ko Yamamoto
, Masahiro Natsuaki
, et al.
·
Circulation Reports
·
3
PDF
Independent Predictors of Major Adverse Cardiovascular Events at 3 Years after Aortoiliac Stent Implantation
2022
·
Yasutaka Yamauchi
, Mitsuyoshi Takahara
, et al.
·
Journal of Vascular and Interventional Radiology
·
3
Two-Year Outcomes of Asymptomatic vs. Symptomatic Patients After Deferral of Revascularization Based on Fractional Flow Reserve ― Insights From the J-CONFIRM Registry ―
2020
·
Kazunori Horie
, Shoichi Kuramitsu
, et al.
·
Circulation Reports
·
3
PDF
Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery Disease
2024
·
Tairo Kurita
, Shoichi Kuramitsu
, et al.
·
Circulation Reports
·
2
PDF
Show more works
View as search
Works count:
42
Citation count:
437
H-index:
10
I10-index:
11
Year
Topic
Type
